Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Malaria journal
- Publicado em
- 17 mar 2025
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
Andrea A Berry, Thomas L Richie, L W Preston Church, Matthew B Laurens, Colleen Boyce, Natasha Kc, Sudhaunshu Joshi, Abra Rachida Koudjra, Lauryn Butler, Mei-Chun Chen et al.
Descritores MeSH
- Malaria, Falciparum
- Malaria Vaccines
- Plasmodium falciparum
- Immunogenicity, Vaccine
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Vaccines, Attenuated
Veja também
Estudos relacionados
- Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
- Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine
- Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
- Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies